These Analysts Cut Their Forecasts On Axon Enterprise After Downbeat Q3 Results - Axon Enterprise…
Benzinga ·
Axon missed Q3 revenue and earnings estimates, cut FY26 guidance, and shares fell 14%; analysts lowered price targets.
Quantinuum Analysts Cut Their Forecasts After Q3 Results - Quantinuum (NASDAQ:QNT)
Axon missed Q3 revenue and earnings estimates, cut FY26 guidance, and shares fell 14%; analysts lowered price targets.
1 sources · 4 articles · updated 2026-11-06 14:14 UTC · business
Coverage
ARS Pharmaceuticals Analysts Cut Their Forecasts After Downbeat Q3 Results - ARS Pharmaceuticals (NASDAQ:SPRY)
Benzinga ·
ARS Pharma missed Q3 earnings and sales estimates; shares rose 5.6% premarket as analysts cut price targets despite neffy progress.
Quantinuum Analysts Cut Their Forecasts After Q3 Results - Quantinuum (NASDAQ:QNT)
Benzinga ·
Quantinuum beats Q3 estimates, raises FY2026 revenue guidance; shares jump 8.1%, while analysts cut price targets despite bullish ratings.
Microchip Technology Analysts Slash Their Forecasts After Q2 Results - Microchip Technology (NASDAQ:MCHP)
Benzinga ·
Microchip beat Q2 earnings and sales estimates but guided Q3 below forecasts. Shares fell 2.1%; analysts cut price targets despite Buy/Overweight calls.